Sign Up to like & get
recommendations!
2
Published in 2023 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51746
Abstract: Use of tacrolimus in mild to moderate myasthenia gravis (MG) is generally limited to glucocorticoid‐refractory cases; the advantage of mono‐tacrolimus over mono‐glucocorticoids is unknown.
read more here.
Keywords:
tacrolimus;
myasthenia gravis;
tacrolimus mono;
mono tacrolimus ... See more keywords